Reena Kartha

University of Minnesota

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (22)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Youssef Roman

Assistant Professor

Virginia Commonwealth University

UNITED STATES

View details

Shen Cheng

Assistant Professor

University of Minnesota

UNITED STATES

View details

Paul J Orchard

University of Minnesota

UNITED STATES

View details

Simon Johnson

Northumbria University

UNITED KINGDOM

View details

James Cloyd

Professor and Director, Center for Orphan Drug Research

University of Minnesota College of Pharmacy

UNITED STATES

View details

Dorian Cheff

Karolinska Institutet

SWEDEN

View details

Neal J Weinreb

Voluntary Associate Professor

University of Miami School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Reena Kartha

Research Interests

Explore related searches

Contact this professor

Articles (22)

Nervonic acid, a long chain monounsaturated fatty acid, improves mitochondrial function in adrenomyeloneuropathy fibroblasts

Model-informed repurposing of eliglustat for treatment and prophylaxis of Shiga toxin-producing Escherichia coli hemolytic-uremic syndrome (STEC-HUS) in children

Organellar crosstalk as a potential therapeutic target for rare neurodegenerative diseases

Biomarker potential of allele-specific extracellular vesicles in Gaucher disease

Investigating mitochondria-lysosome cross-talk in Gaucher disease cells

Intravital microscopy: An innovative approach to track real‐time muscle integrity and pathology in Pompe disease

Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers

Review of methods for estimating the prevalence of rare diseases

Rare Disease Difference Maker® program

Repeated-dose oral -acetylcysteine in Gaucher disease: Pharmacokinetics summary

N-acetylcysteine Pharmacology and Applications in Rare Diseases—Repurposing an Old Antioxidant

Physiologically‐Based Pharmacokinetic Model Development, Validation, and Application for Prediction of Eliglustat Drug–Drug Interactions

Molecular Interactions between Gasotransmitters in Patients with Obstructive Sleep Apnea

Biological Variation in Peripheral Inflammation and Oxidative Stress Biomarkers in Individuals with Gaucher Disease

Translational and clinical pharmacology considerations in drug repurposing for X‐linked adrenoleukodystrophy—A rare peroxisomal disorder

Gaucher disease – more than just a rare lipid storage disease

Nervonic Acid Attenuates Accumulation of Very Long-Chain Fatty Acids and is a Potential Therapy for Adrenoleukodystrophy

Building cross-border collaborations to increase diversity and accelerate rare disease drug development – meeting report from the inaugural IndoUSrare Annual Conference 2021

Neurofilament light chain: A potential marker of neurological disease in Gaucher disease

Development of therapies for rare genetic disorders of GPX4: roadmap and opportunities.

N-Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy

Population Pharmacokinetic Analysis of N-Acetylcysteine in Pediatric Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplant

Collaborators (7)

Youssef Roman

Shen Cheng

Paul J Orchard

Simon Johnson

James Cloyd

Dorian Cheff

Neal J Weinreb

Make your next move.